12th Nov 2020 12:46
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 11 November 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
3,231,734 | 2.51% | 687,609 | 0.53% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
366,484 | 0.28% | 739,005 | 0.57% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
3,598,218 | 2.79% | 1,426,614 | 1.11% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 4 | 203.0100 USD |
| Purchase | 6 | 202.4800 USD |
| Purchase | 13 | 203.1600 USD |
| Purchase | 13 | 203.3100 USD |
| Purchase | 13 | 202.8065 USD |
| Purchase | 98 | 202.7655 USD |
| Purchase | 192 | 202.9054 USD |
| Purchase | 192 | 203.0408 USD |
| Purchase | 250 | 202.7820 USD |
| Purchase | 253 | 202.9610 USD |
| Purchase | 285 | 202.9362 USD |
| Purchase | 293 | 203.2337 USD |
| Purchase | 305 | 204.0378 USD |
| Purchase | 370 | 202.8048 USD |
| Purchase | 536 | 203.0818 USD |
| Purchase | 838 | 203.0026 USD |
| Purchase | 873 | 203.0002 USD |
| Purchase | 928 | 203.0670 USD |
| Purchase | 962 | 202.8126 USD |
| Purchase | 1,103 | 202.8611 USD |
| Purchase | 1,761 | 203.0643 USD |
| Purchase | 2,018 | 203.0335 USD |
| Purchase | 2,147 | 202.9961 USD |
| Purchase | 2,800 | 203.0539 USD |
| Purchase | 2,918 | 203.0114 USD |
| Purchase | 3,710 | 203.0949 USD |
| Purchase | 4,140 | 202.8452 USD |
| Purchase | 5,613 | 202.8956 USD |
| Purchase | 5,894 | 203.0562 USD |
| Purchase | 6,349 | 203.0340 USD |
| Purchase | 7,625 | 202.8180 USD |
| Purchase | 13,471 | 202.9500 USD |
| Purchase | 14,309 | 202.8688 USD |
| Purchase | 14,466 | 202.9399 USD |
| Purchase | 29,403 | 202.8400 USD |
| Purchase | 45,679 | 202.9013 USD |
| Sale | 4 | 203.0100 USD |
| Sale | 6 | 202.7766 USD |
| Sale | 20 | 203.0300 USD |
| Sale | 26 | 203.3100 USD |
| Sale | 75 | 202.8000 USD |
| Sale | 93 | 202.9700 USD |
| Sale | 100 | 202.8900 USD |
| Sale | 186 | 202.9050 USD |
| Sale | 192 | 202.9158 USD |
| Sale | 233 | 202.8824 USD |
| Sale | 305 | 204.0378 USD |
| Sale | 386 | 202.8640 USD |
| Sale | 400 | 202.6825 USD |
| Sale | 431 | 202.9044 USD |
| Sale | 700 | 202.9414 USD |
| Sale | 801 | 202.9188 USD |
| Sale | 873 | 203.0002 USD |
| Sale | 1,000 | 202.9260 USD |
| Sale | 2,352 | 202.8649 USD |
| Sale | 2,822 | 203.0677 USD |
| Sale | 3,269 | 202.8526 USD |
| Sale | 4,849 | 202.8618 USD |
| Sale | 8,127 | 202.8192 USD |
| Sale | 9,824 | 202.8730 USD |
| Sale | 10,057 | 202.9500 USD |
| Sale | 18,928 | 203.0311 USD |
| Sale | 40,518 | 202.9039 USD |
| Sale | 59,759 | 202.9018 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 12 Nov 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected |
|
| If a connected EFM, state nature of connection |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20201112005603/en/
Copyright Business Wire 2020
Related Shares:
Barclays